DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,038 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $108,684 | +0.1% | 435 | 0.0% | 0.01% | 0.0% |
Q1 2024 | $108,628 | +7.9% | 435 | 0.0% | 0.01% | +7.7% |
Q4 2023 | $100,632 | -15.8% | 435 | -9.8% | 0.01% | -23.5% |
Q3 2023 | $119,583 | +3.4% | 482 | 0.0% | 0.02% | +13.3% |
Q2 2023 | $115,680 | -4.8% | 482 | 0.0% | 0.02% | -6.2% |
Q1 2023 | $121,482 | -5.0% | 482 | 0.0% | 0.02% | -11.1% |
Q4 2022 | $127,927 | -9.3% | 482 | -11.4% | 0.02% | -18.2% |
Q3 2022 | $141,000 | +28.2% | 544 | +25.1% | 0.02% | +37.5% |
Q2 2022 | $110,000 | -20.9% | 435 | -8.4% | 0.02% | -5.9% |
Q1 2022 | $139,000 | -10.9% | 475 | 0.0% | 0.02% | -5.6% |
Q4 2021 | $156,000 | +7.6% | 475 | 0.0% | 0.02% | 0.0% |
Q3 2021 | $145,000 | +5.1% | 475 | -7.8% | 0.02% | +12.5% |
Q2 2021 | $138,000 | -4.2% | 515 | -19.5% | 0.02% | -11.1% |
Q1 2021 | $144,000 | +1.4% | 640 | 0.0% | 0.02% | -5.3% |
Q4 2020 | $142,000 | -2.7% | 640 | -5.9% | 0.02% | -13.6% |
Q3 2020 | $146,000 | -36.8% | 680 | -47.9% | 0.02% | -43.6% |
Q2 2020 | $231,000 | +477.5% | 1,304 | +349.7% | 0.04% | +333.3% |
Q1 2020 | $40,000 | -11.1% | 290 | 0.0% | 0.01% | +12.5% |
Q4 2019 | $45,000 | +7.1% | 290 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $42,000 | +2.4% | 290 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $41,000 | +7.9% | 290 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $38,000 | +26.7% | 290 | 0.0% | 0.01% | +14.3% |
Q4 2018 | $30,000 | -28.6% | 290 | -25.6% | 0.01% | -12.5% |
Q3 2018 | $42,000 | -14.3% | 390 | -22.0% | 0.01% | -11.1% |
Q2 2018 | $49,000 | -7.5% | 500 | -7.9% | 0.01% | -10.0% |
Q1 2018 | $53,000 | -19.7% | 543 | -23.9% | 0.01% | +42.9% |
Q4 2017 | $66,000 | +288.2% | 714 | +269.9% | 0.01% | +250.0% |
Q3 2017 | $17,000 | +325.0% | 193 | +348.8% | 0.00% | – |
Q2 2017 | $4,000 | 0.0% | 43 | 0.0% | 0.00% | -100.0% |
Q1 2017 | $4,000 | +33.3% | 43 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $3,000 | 0.0% | 43 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $3,000 | -70.0% | 43 | -59.0% | 0.00% | -50.0% |
Q4 2015 | $10,000 | – | 105 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |